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CC BY-NC-ND license (http://creativeBackground/Purpose: The relationship between temperature variability and HbA1c has been
reported in Caucasians, but not for Asians of Taiwanese origin. This study investigated the
impact of temperature on HbA1c in various groups of Taiwanese with type 2 diabetes in
Taiwan.
Methods: For this longitudinal follow-up study which started in 2006, we recruited a total of
4399 patients with type 2 diabetes who had been regularly followed up at Chi Mei Medical Cen-
ter and obtained local temperature data for 2006 to 2011 from Taiwan’s Central Weather Bu-
reau. We used a generalized estimated equation (GEE) to analyze the HbA1c level and its
change over time with temperature and temperature changes, respectively.
Results: We found a negative correlation between HbA1c and temperature (R Z 0.475,
pZ 0.001). For every 1C decrement in temperature, there was an increase in the risk of hav-
ing a HbA1c level >7% [p < 0.001, adjusted odds ratio (OR): 1.01]. There was a significantly
higher risk of HbA1c > 7% among those in the lowest quartile of temperatures than the highestave no conflicts of interest relevant to this article.
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344 K.-J. Tien et al.quartile (pZ 0.0038, adjusted OR: 1.13). Patients with diabetic patients were at higher risk of
HbA1C > 7% in the winter and spring than those in the summer (adjusted OR: 1.13, pZ 0.0027;
adjusted OR: 1.14, pZ 0.0022). After adjusting for various confounders, we found people who
were younger than 65 years old, people who had diabetes for longer than 6 years, and people
who had a body mass index (BMI) < 24 to be more susceptible to temperature changes
(p Z 0.0022, b: 0.0095; p < 0.0001, b: 0.0125; p < 0.0001, b: 0.016, respectively).
Conclusion: Our study suggests cold weather may adversely affect HbA1c levels in Taiwanese
people with type 2 diabetes, especially in people under 65 years old, people with diabetes for
longer than 6 years, and those with a BMI < 24.
Copyright ª 2015, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
The glycated hemoglobin A1c (HbA1c) level, a calculation
of average glycemia over several months, is often used as
a primary target in the treatment of diabetes. The
American Diabetes Association (ADA) recommends that it
should be calculated approximately every 3 months to
determine whether a patient has reached and maintained
this glycemic goal.1 This goal may be important because
the UK Prospective Diabetes Study (UKPDS) found a 14%,
37%, and 21% reduction in myocardial infarction, micro-
vascular complications, and diabetes-related death for
each 1% reduction in HbA1c.2 However, a lower HbA1c
level may not bring cardiovascular (CV) benefit. Intensive
glycemic control has been found to show no significant
reductions in CV outcomes in Action in Diabetes and
Vascular Disease Preterax and Diamicron Modified Release
Controlled Evaluation (ADVANCE) and the Veterans Affairs
Diabetes Trial (VADT).3,4 In fact, intensive glycemic con-
trol with a target A1C of <6% increased mortality in the
Action to Control Cardiovascular Risk in Diabetes
(ACCORD) trial.5 Hence, it should be mentioned that gly-
cemic goals be individualized and achieved safely in the
ADA position statement.6
Fluctuations of HbA1c have been associated with sea-
sonal change7e9 as well as some physiological endocrine
factors, environmental factors and social events.10e12
Caney et al reported HbA1c levels in women with type 2
diabetes were susceptible to temperature.13 A study of
type 1 diabetes, found a correlation between temperature
and HbA1c in schoolchildren, but not preschoolers.14 In our
daily clinical experience, some groups appear to be more
vulnerable to temperature variation than others. However,
few studies focus on the risk that temperature may pose to
different subgroups. The studies that have focused on this
topic have been conducted in Caucasian populations,9,15,16
and most are either cross-sectional in design or have small
sample sizes.13,16 Cross-sectional studies, in particular, may
produce biased results when applied to changes that occur
over time.
Therefore, this investigation used a follow-up study
design to observe HbA1c changes and temperature changes
over a period of 5 years (from Jan 2006 to Jan 2011) in 4399Taiwanese patients with type 2 diabetes and subgroups of
this population in Taiwan.
Materials and methods
This observational follow-up study enrolled 4399 type 2
diabetic patients recruited from the diabetic clinic in the
Metabolism Division at Chi Mei Medical Center in Tainan, a
city located near the southwest coast of Taiwan. At
enrollment in Jan 2006, all patients had been regularly
followed up at least 6 months. Regular follow-ups were also
performed for these patients during the study period which
ended Jan 2011. All the patients participated in a
comprehensive diabetes care program.17 Physicians, dia-
betes educators, and dietitians cooperate to provide inte-
grated and comprehensive care for each patient at every
quarterly outpatient department visit. Data on sex, age,
date of diagnosis of diabetes, and biophysical measure-
ments such as triglyceride (TG), total cholesterol (TC), high
density lipoprotein and low density lipoprotein cholesterol
(HDL-C and LDL-C), blood pressure (BP) and body mass
index (BMI) for each patient were collected for each pa-
tient at baseline and at 1 year. HbA1c, creatinine, and
estimated glomerular-filtration rate (eGFR) were checked
and recorded at baseline and every 3 months. The eGFR
was calculated using the equation recommended by the
National Kidney Foundation in the Modified Diet in Renal
Disease. All antihypertensive, glucose-lowering, and lipid-
lowering medications were also recorded every 3 months.
Local temperature data from 2005 to 2011 were obtained
from Taiwan’s Central Weather Bureau (http://www.cwb.
gov.tw/V7e/climate/monthlyData/mD.htm).
Statistical analyses
All values were reported as means  SD or median with
interquartile ranges or percentages. Because the distribu-
tion of TG was highly skewed, the variable was natural log
transformed for all other analyses. We analyzed the odds
ratio (OR) for HbA1C > 7% for seasons as categorical vari-
ables. We classified December to February as winter, March
to May as spring, June to August as summer, and September
to November as fall/autumn. Categorical cut-off points for
Table 1 The clinical characteristics of the patients and
biophysical measurements at baseline and final visit.
Total numbers 4399
Follow up 0.5w1 year 1414(32.14%)
Follow up 1w3 year 1801(40.94%)
Follow up 3w5 year 1184(26.92%)
Mean follow-up years 2.06  1.29
DM duration (y) 7.94  7.04
Sex (Male/Female) 2194/2205
Age (y) 62.05  12.44
Smoking (yes/no) 723/3676
Biophysical data Baseline Last
SBP (mmHg) 136.88  19.56 136.71  19.30
DBP (mmHg) 79.70  11.64 77.89  11.12
BMI (kg/m2) 25.69  4.11 25.71  4.09
AC sugar 152.02  53.87 141.91  50.65
Hb A1C (%) 8.17  1.82 7.80  1.52
CHOL (mg/dL) 193.86  42.62 169.74  38.84
TG (mg/dL) 151.07  117.24 136.12  103.72
Ln (TG) (mg/dL) 4.84  0.57 4.74  0.55
HDL-C (mg/dL) 52.99  13.90 51.48  13.75
LDL-C (mg/dL) 121.91  38.43 99.93  33.08
Creatinine (mg/dL) 1.07  0.47 1.17  0.75
eGFR (mL/min per
1.73 m2)
63.97  21.67 61.78  23.26
Use of antihypertensive treatment (%)
ACEI 307(6.98%) 316(7.18%)
ARB 895(20.35%) 875(19.89%)
CCB 1052(23.91%) 1084(24.64%)
Diuretics 255(5.80%) 235(5.34%)
b-blocker 319(7.25%) 333(7.57%)
Use of lipid-lowering medications (%)
Statin 1382(31.42%) 1390(31.60%)
Fibrates 502(11.41%) 473(10.75%)
Statin þ fibrates 81(1.84%) 96(2.18%)
None 2434(55.33%) 2440(55.47%)
Temperature and HbA1c in type 2 diabetes 345temperature were analyzed into quartiles. Because the
study variables were recorded more than once during this
study, the OR of HbA1c >7% for temperature as continuous
or categorical variables (quartile as cut points: <21.8C,
21.8C w26.3C, 26.3C w28.4C, >28.4C) was obtained
by logistic regression using the generalized estimated
equation (GEE) method clustering each patient in this lon-
gitudinal data. The correlation matrix was set as
exchangeable. GEE is often used to analyze longitudinal
and other correlated response data, particularly if re-
sponses are binary. We calculated all the HbA1C changes for
each person and the temperature changes during the study
period in the GEE model.
This model helped control for those repeated variables
rather than just using their values from baseline. We also
adjusted the model for known confounders: age, sex, dia-
betes duration, BMI, eGFR, smoking, and use of lipid-
lowering, antihypertension and glucose-lowering drugs.
A mixed effects model was used to define at-risk sub-
groups [male, female, age  65, age > 65, DM duration  6
years, DM duration > 6 years, BMI <24, 24  BMI  27,
BMI > 27, eGFR 60, eGFR > 60, only diet control, only oral
antidiabetes drugs (OAD), only insulin, and OAD þ insulin]
when the dependent variable HbA1C was treated as a
continuous outcome. In this method, a random intercept is
fitted for each patient and the weighted effect of repeated
measurements was taken into account. The three models
demonstrated the change of HbA1c for every 1C decre-
ment in temperature. Model 1 was an unadjusted model,
Model 2 was adjusted for age, sex, diabetes duration, BMI,
eGFR and smoking status, and Model 3 was adjusted for the
same adjusted variables of model 2 plus use of lipid-
lowering, antihypertension, and glucose-lowering drugs.
Afterwards, Pearson’s correlation coefficient was per-
formed to address the relationship of mean HbA1c of each
patient and temperature. All statistical tests were two-
sided. A p value of <0.05 was considered significant.Use of glucose-lowering treatment (%)
Diet only 120(2.73%) 99(2.25%)
OAD therapy only
Monotherapy 917(20.85%) 877(19.94%)
Two combinations 1819(41.35%) 1847(41.99%)
Three combinations 816(18.55%) 824(18.73%)
Insulin therapy only 278(6.32%) 277(6.30%)
OAD puls insulin 449(10.21%) 475(10.80%)
ACEI Z angiotensin converting enzyme inhibitor;
ARBZ angiotensin II receptor blocker; BMIZ body mass index;
CCB Z calcium channel blocker; DBP Z diastolic blood pres-
sure; FPG Z fasting plasma glucose; HDL-C Z high density li-
poprotein cholesterol; LDL-C Z low density lipoprotein
cholesterol; OAD Z oral antidiabetes drugs; SBP Z systolic
blood pressure; TC Z total cholesterol; TG Z triglyceride.Results
As can be seen in Table 1, a summary of the clinical char-
acteristics of the patients, two-thirds of the 4399 type 2
diabetic patients we studied were followed up for at least 1
year. The mean follow-up period was 24.7 months. In total,
21,279 measurements of HbA1C were recorded during the
study period. During this time, there were improvements in
nearly all biophysical parameters, especially HbA1c and LDL
cholesterol, as they were the focus of treatment.
As shown in Fig. 1, a depiction of the relationship be-
tween the temperature and HbA1c levels, we found a
strong negative correlation between HbA1c and tempera-
ture (R Z 0.475, p Z 0.001).The lower the temperature,
the higher the HbA1c.
We further categorized temperature as continuous or
categorical variables to analyze the ORs of HbA1c > 7%
(Table 2). Every 1C decrement in temperature increased
the risk of HbA1c > 7% (OR: 1.01, 95% CI: 1.01e1.02,
p < 0.001). After adjusting for confounding factors (age,
sex, diabetes duration, BMI, eGFR, smoking, use of lipid-
lowering, antihypertension and glucose-lowering drugs),
the risk remained significantly higher (OR: 1.01, 95% CI:1.01e1.02, p < 0.001). We divided the temperatures into
quartiles in the categorical analysis and used those in the
highest quartile as the reference group. The group
belonging to the lowest quartile were found to be at higher
risk of HbA1c > 7% than the group belonging to the highest
quartile in both unadjusted and adjusted models (OR: 1.12,
95% CI: 1.06e1.19, p < 0.001 and OR: 1.13, 95% CI:
1.04e1.22, p Z 0.0038). Table 3 showed that diabetic
Figure 1 Correlation of HbA1c levels (%) and temperature
(C) (R Z 0.475, p Z 0.001).
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(HbA1C > 7%) in the winter and spring than those in the
summer (adjusted OR: 1.13(1.04e1.22), p Z 0.0027;
adjusted OR: 1.14(1.05e1.25), p Z 0.0022, respectively).
Table 4 shows the changes in HbA1c analyzed by every
1C decrement in temperature. We classified the clinical
phenotype of the population to determine which risk sub-
groups may be prone to these effects. Almost all pheno-
types were influenced by temperature; both men and
women were significantly influenced by temperature in
both the unadjusted and adjusted models. In patients with
age 65, every 1C decrement in temperature significantly
was associated with a 0.0095 unit increment in HbA1C, but
not in those with age >65. Temperature changes also had a
greater impact on patients who had diabetes for more than
6 years than for those who had it for 6 years or less
(adjusted b: 0.0125, p < 0.0001; adjusted b: 0.0013,Table 2 Odds ratios for HbA1C > 7% for temperature as contin
Interpretation Unadjusted OR (95%
Continuous Every 1C decrement 1.01 (1.01e1.02)
Categorical <21.8 1.12 (1.06e1.19)
21.8w26.3 1.10 (1.04e1.17)
26.3w28.4 1.00 (0.94e1.07)
>28.4 Reference
Adjust for age, sex, diabetes duration, BMI, eGFR, smoking, use of li
Table 3 Odds ratios for HbA1C>7% for seasons as categorical v
Interpretation Unadjusted OR (95% CI)
Categorical Spring 1.13 (1.07e1.20)
Summer Reference
Fall 1.01 (0.96e1.06)
Winter 1.12 (1.06e1.19)
Adjust for age, sex, diabetes duration, BMI, eGFR, smoking, use of lip Z 0.7076, respectively). We found similar changes in
those with BMI <24, but not in those with BMI 24e27 and
>27. On average, there was a 0.016 unit increment in
HbA1c level in those with BMI <24.Discussion
Although there were many studies investigating the epide-
miology and treatment of diabetes in Taiwan, the impact of
ambient temperature on glycemic control was rarely dis-
cussed.18e21 To our knowledge, this is the first 5-year
observational study investigating the association between
the temperature and HbA1c in patients with type 2 diabetes
in Taiwan. We found a negative correlation between HbA1c
and temperature: the lower the temperature, the poorer
the glycemic control. The patients belonging to the lowest
quartile of temperature had a 13% higher risk for HbA1c >
7%, compared with those belonging to the highest quartile.
Although nearly all the tested subgroups are affected by
the temperature, patients aged <65 years, those with
diabetes longer than 6 years, and those with BMI <24 were
more likely to be influenced by the temperature changes
after adjusting for potential confounders.
Our findings demonstrate a seasonal variation in HbA1c
levels. The risk of having a HbA1c > 7% was higher in those
in the lowest quartile of temperatures than the highest.
Most of the previous investigations were cross-sectional in
design, had a small number of subjects, and had subjects of
different ethnicities.8,14,22,23 Our study was a 5-year follow-
up study. In a cross-sectional study design, the HbA1c used
for analysis was calculated from the mean HbA1c level in
this population and so it is difficult to see the real impact of
temperature on an individual patient. Some patients have
been found to have seasonal HbA1c fluctuations and some
patients show a reverse pattern of HbA1c fluctuations.24
There are some plausible explanations for temperature
associated changes in HbA1c in our study. Ishii et al8 re-
ported an increase in dietary intake and decrease inuous or categorical variables.
CI) p Adjusted OR (95% CI) p
<0.001 1.01 (1.01e1.02) <0.001
<0.001 1.13 (1.04e1.22) 0.0038
0.0011 1.09 (1.00e1.18) 0.0459
0.9371 0.99 (0.92e1.08) 0.9234
Reference
pid-lowering, antihypertension, and glucose-lowering drugs.
ariables.
p Adjusted OR (95% CI) p
<0.0001 1.14 (1.05e1.25) 0.0022
Reference
0.7574 0.98 (0.91e1.06) 0.5931
<0.0001 1.13 (1.04e1.22) 0.0027
pid-lowering, antihypertension, and glucose-lowering drugs.
Table 4 Unadjusted and adjusted model between HbA1c and temperature in subgroup analysis (every 1C decrement).
Subgroup Model 1 (unadjusted) Model 2 (adjusted) Model 3 (adjusted)
Estimate of HbA1c b(95% CI) p Estimate of HbA1c b(95% CI) p Estimate of HbA1c b(95% CI) p
Sex
Male 0.0111 (0.0058e0.00164) <0.0001 0.0082 (0.0014e0.0150) 0.0182 0.0084 (0.0016e0.0151) 0.0157
Female 0.0087 (0.0041e0.0132) 0.0002 0.0063 (0.0003e0.0122) 0.0386 0.0061 (0.0002e0.0120) 0.0437
Age
65 0.0116 (0.0069e0.0164) <0.0001 0.0094 (0.0033e0.0155) 0.0025 0.0095 (0.0034e0.0156) 0.0022
>65 0.0073 (0.0022e0.0123) 0.0048 0.0041 (0.0254e0.0106) 0.2285 0.0042 (0.0024e0.0108) 0.2087
Diabetes duration
6 y 0.0057 (0.0005e0.0108) 0.0304 0.0016 (0.0050e0.0083) 0.6289 0.0013 (0.0053e0.0079) 0.7076
>6 y 0.0138 (0.0091e0.0185) <0.0001 0.0122 (0.0062e0.0183) <0.0001 0.0125 (0.0065e0.0186) <0.0001
BMI
<24 0.0190 (0.0130w0.0249) <0.0001 0.0160 (0.0082w0.0237) <0.0001 0.0160 (0.0082w0.0237) <0.0001
24e27 0.0071 (0.0014w0.0128) 0.0143 0.0053 (0.0020w0.0127) 0.1561 0.0054 (0.0020w0.0127) 0.1515
>27 0.0042 (0.0017w0.0102) 0.1650 0.0017 (0.0060w0.0094) 0.6696 0.0012 (0.0064w0.0088) 0.7496
eGFR
60 0.0095 (0.0052w0.0138) <0.0001 0.0078 (0.0014w0.0141) 0.0169 0.0082 (0.0018w0.0145) 0.0117
>60 0.00121 (0.0057w0.0185) 0.0002 0.0089 (0.0025w0.0154) 0.0064 0.0088 (0.0024w0.0152) 0.0069
Use of glucose-lowering drugs
Only diet control 0.0102 (0.0043w0.0247) 0.1683 0.0100 (0.0102w0.0301) 0.3321 0.0093 (0.0111w0.0297) 0.3717
Only OAD 0.0095 (0.0057w0.0133) <0.0001 0.0066 (0.0017w0.0115) 0.0090 0.0064 (0.0015w0.0113) 0.0108
Only insulin 0.0197 (0.0041w0.0353) 0.0134 0.0248 (0.0062w0.0434) 0.0092 0.0255 (0.0070w0.0441) 0.0071
OAD þ insulin 0.0087 (0.0039w0.0213) 0.1754 0.0002 (0.0166w0.0163) 0.9816 0.0003 (0.0162w0.0167) 0.9760
Model 2: adjust for age, sex, diabetes duration, BMI, eGFR, and smoking.
Model 3: adjust for model 2, use of lipid-lowering, antihypertension, and glucose-lowering drugs.
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348 K.-J. Tien et al.outdoor activity during periods with colder temperatures in
their diabetic patients. This is understandable because
physical activity has been found to be lower during winter
and increased during warmer months.25 We also found an
increase in body weight during the colder periods in our
study population (data not shown), which is consistent with
decreased physical activity and the increased calorie
intake. Chen et al11 reported that Chinese patients with
type 2 diabetes have poorer glycemic control during holi-
days. There are a series of holidays that may present pa-
tients with more opportunity for greater calorie
consumption, such as the mid-autumn festival with its big
dinners and traditional high-caloric “moon cakes” and
candies, Christmas with its traditional big dinners, candies
and cookies, New Year with its party snacks and alcoholic
beverages, and Chinese New Year with the traditionally
elaborate dinners with family members over several days
and consumption of candies and snacks on visits to the
homes of friends and relatives, and the Lantern Festival
with the traditional consumption of sweet glutinous rice
dumplings. Not only diabetic patients, but also most others
relax vigilance and pay less attention to glycemic control
during these periods. Some physiologic and endocrine fac-
tors have seasonal variation also. For example, plasma
glucagon and free fatty acid levels are higher in winter and
have been associated with ambient temperatures.26 Plasma
cortisol concentrations and glucocorticoid activity are
higher in winter.27 Some studies also reported that vitamin
D and melatonin affect glucose tolerance and insulin
sensitivity.28,29
Previous studies have rarely focused on which patients
would characteristically be at higher risk for this effect.
Although all subpopulations in this study experienced
temperature-associated HbA1c variability, some of them
were particularly more susceptible to the effect of tem-
perature than others. Few studies have evaluated the
gender differences in HbA1c during temperature changes.
One study by Carney et al13 reported that women had
higher seasonal HbA1c variability than men. In our study,
we found the glycemic control in male and female groups to
be influenced by the temperature, with HbA1c change
seemingly greater in number in men. The interaction of sex
and seasonal effect was assessed, but we found no signifi-
cant effect between sex and seasonal effect (pZ 0.1264 in
the continuous model). One reason for this difference may
be related to gender-dependent lifestyle patterns and
physiological response to temperature. One study investi-
gating seasonal effect in men and women found that men
consumed more kilocalories, carbohydrate, sugar, and
starch than women in cold temperatures.30 Another study
by Kuroshima et al26 demonstrated glucagon levels to be
higher in men than women, and insulin sensitivity was
reduced in the winter season.
Patients younger than 65 years tended to have greater
HbA1c changes during temperature decreases in this study.
The exact reason for the phenomenon is not known.
Adherence to medical recommendations should be consid-
ered. One study by Curkendall et al31 showed that type 2
diabetes patients who were older (aged > 65 years) were
more likely to be compliant. In our study, patients who had
DM for >6 years were more prone to HbA1c variability thanthose who had it for shorter durations, a finding that might
be explained by an increase in beta cell dysfunction that
occurs with disease progression. In addition, in our study,
patients with lower BMI were more prone to the HbA1c
variability than the patients with higher BMI. The precise
mechanisms underlying these fluctuations are not known.
One investigation performed in a Chinese population re-
ported an association between higher BMI and higher insulin
secretion as well as beta cell function.32 Higher insulin
secretion may compensate for the increases in dietary
intake during seasonal reductions in temperature. Another
reason might be related to medical attention. Overweight
or obese diabetic patients were being treated at our med-
ical facility, which provides a comprehensive diabetes care
program that includes dietary consultation. Overweight or
obese patients in this program are educated on ways to
reduce weight and control calories in daily practice. These
patients may have been paying more attention to dietary
and lifestyle patterns. The clinicians as well as the thinner
patients may have overlooked diet and weight education
part of the program, thinking it was unnecessary. This is
conjecture, of course, and would require further research
to study the possible connection between diet and seasonal
variability in HbA1c.
This study has some limitations. First, we recorded the
corresponding class of glucose-lowering drugs (e.g., sulfo-
nylurea, metformin, thiazolidinedione) at the same time
we recorded the biochemical data. Hence, we could adjust
the class of the glucose-lowering drugs in the analysis and
reduce the confounding from antidiabetic medications.
Although we recorded which drug classes were being taken
at each time, we did not record the dosage of those drugs,
which may have confounded our results. Generally, the
physicians in Taiwan follow the recommendations by The
Diabetes Association of the Republic of China and adjust
the antidiabetic medications to achieve the glycemic goals.
Even under these circumstances, the temperature effect on
HbA1c still existed in the present study. We believe the
temperature should play some role in the glycemic control
in type 2 diabetes in Taiwan. Furthermore, we tried to
minimize the bias by enrolling patients who had been
regularly followed up at our clinics at least for 6 months, as
they were probably taking relatively more stable doses of
glucose-lowering agents. Second, we performed sensitivity
analysis for seasonal effects. The receiver operating char-
acteristic curve showed that the area under the curve
(AUC) was 0.518 (p < 0.001, figure not shown). Although the
p-value suggests significance, the AUC belongs to low
discrimination area. The impact of temperature on the
glycemic control in Taiwan seems to be limited. Taiwan is
located in a subtropical area and the range of the tem-
perature is relatively narrow, which may limit the tests’
discriminate ability. Third, it is difficult for the present
study design to identify key determinants of the tempera-
ture effect, one being temperature itself or other factors
associated with the temperature. Future study may be
needed to record the physical exercise level, diet calorie,
hormone level, and other possible factors in detail to clarify
the effect.
In conclusion, this observational follow-up study found a
negative correlation between HbA1c and temperature in
Temperature and HbA1c in type 2 diabetes 3494399 Taiwanese patients with type 2 diabetes, especially
patients below 65 years old, those with diabetes for over 6
years, and those with lower BMIs. These findings suggest
that clinicians might want to take HbA1c variability into
account when treating diabetes, especially for those more
at risk.
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